Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
C. Pavlovsky
Observed names:
C Pavlovsky,
Pavlovsky, C.
Institution:
Fundación para la Investigación, Docencia y Prevención del Cáncer
Observed institution:
Fundación para la Investigación, Docencia y Prevención del Cáncer
ORCID:
0000-0001-7555-5535
Observed ORCID:
0000-0001-7555-5535
OpenAlex ID:
A5067064349
S881 Pregnancy Outcome in Female Patients With Chronic Myeloid Leukemia Worldwide: Analysis of 305 Cases of the European Leukemia Net Registry
2019
·
E. Chelysheva
, A. Turkina
, et al.
·
HemaSphere
·
13
BTK and PLCG2 mutations in patients with Chronic Lymphocytic Leukemia relapsing on Ibrutinib: a European Research Initiative on CLL (ERIC) study based on real-world evidence
2020
·
Lydia Scarfò
, Silvia Bonfiglio
, et al.
·
5
P715: Multicenter Observational Study of Ponatinib in Cml Patients in Argentina. Real-world Experience.
2022
·
M. J. Mela Osorio
, M. V. Osycka
, et al.
·
HemaSphere
·
4
Evaluación clínica y de respuesta al tratamiento de pacientes con leucemia mieloide aguda. Estudio multicéntrico.
2017
·
MJ Mela Osorio
, AD Gimenez Conca
, et al.
·
Revista Hematología
·
3
PDF
Monitoring response to imatinib by quantitative real-time polymerase chain reaction (RQ-PCR) in chronic phase, chronic myeloid leukemia patients in complete cytogenetic remission
2008
·
C. Pavlovsky
, I. Giere
, et al.
·
Journal of Clinical Oncology
·
1
Leucemia mieloide crónica: ¿Es posible la remisión libre de tratamiento fuera de ensayos clínicos?
2024
·
C Pavlovsky
, RK Tannuri
·
Revista Hematología
PDF
Results of Mutational Status of Immunoglobulin Heavy‐chain Variable Genes Analysis in a Cohort of Patients With B‐cll. a Single Centre Experience
2019
·
C. Mardaraz
, F. Sackmann
, et al.
·
Hematological Oncology
Pb1903 Improvement in Patient‐reported Outcomes (pros) and Fatigue in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib (ibr) Monotherapy: Report of Real World Experience.
2019
·
M.J. Mela Osorio
, A. Pavlovsky
, et al.
·
HemaSphere
Ps1186 Current Dose Recommendations for Ponatinib in Chronic Myeloid Leukemia Patients Can Diminish Adverse Events While Maintaining Efficacy
2019
·
V. Garcia‐Gutierrez
, J.C. Hernandez‐Boluda
, et al.
·
HemaSphere
Hidroxiurea en neoplasias mieloproliferativas Ph negativas: experiencia en la Argentina.
2019
·
Georgina Bendek
, Ángeles Vicente
, et al.
·
Revista Hematología
PDF
Show more works
View as search
Works count:
11
Citation count:
26
H-index:
3
I10-index:
1
Year
Topic
Type